COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 1007: Articles 10061-10070  | Next

Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination
Lane, S., Yeomans, A., Shakir, S.
10.1101/2021.12.20.21268102 — Posted: 2021-12-21
Protection following BNT162b2 booster substantially exceeds that of a fresh 2-dose vaccine: a quasi-experimental study
Amir, O., Goldberg, Y., Mandel, M., Bar-On, Y. M., Bodenheimer, O., Alroy-Preis, S., Ash, N., Huppert, A., Milo, R.
10.1101/2021.12.19.21267933 — Posted: 2021-12-21
Analysis of cutoff point estimation for determining seropositivity in the context of SARS-CoV-2 infections
Domingues, T. D., Mourino, H., Sepulveda, N.
10.1101/2021.12.20.21268100 — Posted: 2021-12-21
KNOWLEDGE, ATTITUDES AND PRACTICE AMONG HEALTHCARE WORKERS TOWARDS COVID 19 PREVENTIVE MEASURES AT WOMEN AND NEW BORN HOSPITAL OF THE UNIVERSITY TEACHING HOSPITALS IN LUSAKA ZAMBIA
Shampile, J. N., Lingenda, G., Zambwe, M., Chipimo, P. J.
10.1101/2021.12.20.21267829 — Posted: 2021-12-21
Worldwide clustering and infection cycles as universal features of multiscale stochastic processes in the SARS-CoV-2 pandemic
Mitrovic Dankulov, M., Tadic, B., Melnik, R.
10.1101/2021.12.20.21268095 — Posted: 2021-12-21
Effectiveness of different booster regimens for preventing infection and adverse outcomes in Puerto Rico
Irizarry, R. A., Robles Fontan, M. M.
10.1101/2021.12.19.21268070 — Posted: 2021-12-21
Factors associated with COVID-19 vaccine hesitancy in Senegal: a mixed study
Ba, M. F., Faye, A., Kane, B., Diallo, A. I., Junot, A., Gaye, I., Bonnet, E., Ridde, V.
10.1101/2021.12.20.21267724 — Posted: 2021-12-21
The Place of Fluvoxamine in the Treatment of Non-critically ill Patients with COVID-19: A Living Systematic Review and Meta-analysis
Kacimi, S. E. O., Greca, E., Haireche, M. A., Sallam ElHawary, A., Ould Setti, M., Caruana, R., Rizwan, S., Benyettou, H., Yasir Essar, M., Shah, J., Ghozy, S.
10.1101/2021.12.19.21268044 — Posted: 2021-12-21
Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in samples from vaccinated individuals
Urlaub, E., Hayer, J.
10.1101/2021.12.17.21267927 — Posted: 2021-12-21
RESISTANCE CONFERRING MUTATIONS IN SARS-CoV-2 DELTA FOLLOWING SOTROVIMAB INFUSION
Rockett, R. J., Basile, K., Maddocks, S., Fong, W., Agius, J. E., Johnson-Mackinnon, J., Arnott, A., Chandra, S., Gall, M., Draper, J. L., Martinez, E., Sim, E. M., Lee, C., Ngo, C., Ramsperger, M., Ginn, A. N., Wang, Q., Fennell, M., Ko, D., Lim, L., Gilroy, N., Sullivan, M. V., Chen, S. C.-A., Kok, J., Dwyer, D. E., Sintchenko, V. L.
10.1101/2021.12.18.21267628 — Posted: 2021-12-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).